...
首页> 外文期刊>European spine journal >A validated preoperative score predicting survival and functional outcome in lung cancer patients operated with posterior decompression and stabilization for metastatic spinal cord compression
【24h】

A validated preoperative score predicting survival and functional outcome in lung cancer patients operated with posterior decompression and stabilization for metastatic spinal cord compression

机译:经验证的术前评分可预测肺癌患者的后路减压和稳定度,以评估转移性脊髓压迫的生存率和功能结局

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PurposeThis study aims to create and validate a score for survival and functional outcome of lung cancer patients with metastatic spinal cord compression (MSCC) after posterior decompressive surgery.MethodsThe entire cohort of 73 consecutive patients was randomly assigned to a test group (N?=?37) and a validation group (N?=?36). In the test group, we retrospectively analyzed 10 preoperative characteristics. Characteristics significantly associated with survival on multivariate analysis were included in the score. Patients in the validation group were used to confirm whether the score was reproducible. Postoperative functional outcome was analyzed both in the test and validation groups.ResultsOn multivariate analysis, preoperative ambulatory status (P?=?0.0017), visceral metastases (P?=?0.0002), and time developing motor deficits (P?=?0.0004) had significant impact on survival and were included in the scoring system. According to the prognostic scores, which ranged from 0 to 6 points, two risk groups were designed: 0–2 and 3–6 points and the median survival was 2.6?months (95?% CI, 1.0–3.8?months) and 10.7?months (95?% CI, 7.1–13.7?months), respectively (P??0.0001). In the validation group, the corresponding median survival was 2.7?months (95?% CI, 1.6–5.5?months) and 10.8?months (5.8–13.6?months), respectively (P??0.0001). In addition, the functional outcome was worse in patients with 0–2 points than in patients with 3–6 points both in the test (P?=?0.0023) and validation groups (P?=?0.0298).ConclusionPatients with scores of 0–2 points, who have short survival time (life expectancy?less than 3?months) and poor functional outcome, appear best treated with radiotherapy or best supportive care alone. Surgery may be no longer in consideration in most of the patients in this group. Patients with score of 3–6 points should be surgical candidates, because survival prognosis (life expectancy more than 10?months) and functional outcome are favorable after surgery...
机译:目的本研究旨在创建和验证后减压手术后转移性脊髓压缩(MSCC)肺癌患者的生存和功能结局评分。方法将73例连续患者的整个队列随机分配到一个测试组中(N?=? 37)和验证组(N?=?36)。在测试组中,我们回顾性分析了10个术前特征。得分包括与多因素分析中与生存显着相关的特征。验证组中的患者用于确认评分是否可重复。在测试组和验证组中均分析了术后功能结局。结果进行多变量分析,术前门诊状态(P = 0.0017),内脏转移(P = 0.0002)和运动功能障碍时间(P = 0.0004)。对生存率有重大影响,并计入评分系统。根据预后评分(从0到6分),设计了两个风险组:0–2和3–6分,中位生存期为2.6个月(95%CI,1.0到3.8个月)和10.7个月。个月(95%CI,7.1-13.7个月)(P 0.0001)。在验证组中,相应的中位生存期分别为2.7个月(95%CI,1.6-5.5个月)和10.8个月(5.8-13.6个月)(P 0.0001)。此外,在测试组(P = 0.0023)和验证组(P = 0.0298)中,0–2分的患者的功能结局比3–6分的患者要差。结论得分为0的患者生存时间短(预期寿命少于3个月)且功能预后较差的–2分似乎仅接受放疗或最佳支持治疗即可得到最佳治疗。该组中的大多数患者可能不再考虑手术。得分为3–6分的患者应作为手术候选人,因为手术后生存预后(预期寿命超过10个月)和功能结局良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号